4//SEC Filing
Imran Talat 4
Accession 0000950170-23-062001
CIK 0001856725other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:05 PM ET
Size
6.0 KB
Accession
0000950170-23-062001
Insider Transaction Report
Form 4
Imran Talat
DirectorChief Executive Officer
Transactions
- Purchase
Class A Common Stock
2023-11-07$1.98/sh+2,500$4,950→ 446,955 total - Purchase
Class A Common Stock
2023-11-07$2.01/sh+2,500$5,025→ 449,455 total
Footnotes (1)
- [F1]Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001869579
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:05 PM ET
- Size
- 6.0 KB